Parvovirus B19 - Biotrin International


	Welcome to Biotrin

Biotrin is a healthcare company that specialises in providing a range of novel and proprietary tests for the clinician and research scientist. Biotrin’s headquarters are in Dublin, Ireland where it conducts its research and development, manufacturing and marketing activities.


	News

	3 Oct 2011	Biotrin Group officially opens new facility in Dublin
	5 May 2011	DIASORIN AND PRECISION SYSTEM SCIENCE CO., LTD SIGN AN AGREEMENT TO DEVELOP A MOLECULAR DIAGNOSTIC ANALYZER FOR LAMP ASSAYS.
	17 Jun 2010	Biotrin Group Announce Research and Development project for Dublin with the Creation of 40 new jobs
	25 Mar 2010	BioMedica Conference, Dublin, Ireland 27th-28th April 2010
	25 Mar 2010	Clinical Virology Symposium, Daytona Beach, Florida USA, April 25-28th 2010
	30 Aug 2009	Important information regarding the detection of the H1N1 (Swine Flu) antigen by the Biotrin Respiratory Virus Panel IFA kit.

Infectious Diseases

Biotrin’s lead product range are tests to detect Parvovirus B19, a viral infection that can cause miscarriage in pregnant women. Biotrin is the world leader in Parvovirus B19 testing and the only company to have FDA cleared tests. Other CE marked tests: HHV-6, HHV-8, Respiratory viruses and Hantavirus.

The biomarkers division of Biotrin International has been spun out into an independent company called Argutus Medical Ltd.

Please Click Here to access the Argutus Medical website

Manufacturing / Quality Assurance: 93 The Rise, Mount Merrion, Stillorgan, Co. Dublin, Ireland.
Administration / R&D: Unit 13/14 Holly Avenue, Stillorgan Industrial Park, Blackrock, Co. Dublin, Ireland.
Tel: +353 1 283 1166 | Fax: +353 1 283 1232
Email: info@biotrin.ie
For technical support please email: customercare@biotrin.ie
Company No. 422701